Quel est le prix pour Jiangsu Recbio Technology Co., Ltd. (2179)

Le prix pour Jiangsu Recbio Technology Co., Ltd. (2179) est $0.65882008

Quelle est la capitalisation boursière pour Jiangsu Recbio Technology Co., Ltd. (2179)

La capitalisation boursière pour Jiangsu Recbio Technology Co., Ltd. (2179) est $349.34M

Jiangsu Recbio Technology Co., Ltd. (2179) Prix et Capitalisation Boursière

Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.

Prix pour 2179	L’actif B	La capitalisation boursière de B	Résultats
$10,229.69 $349.34M	NVDA	$5.424T	+1,552,628.87%
$9,006.86 $349.34M	AAPL	$4.776T	+1,367,019.84%
$7,641.33 $349.34M	GOOG	$4.052T	+1,159,750.37%
$6,960.94 $349.34M	MSFT	$3.691T	+1,056,476.92%
$5,175.38 $349.34M	AMZN	$2.744T	+785,452.44%

Prix pour 2179

L’actif B

La capitalisation boursière de B

Résultats

$10,229.69 $349.34M